Patents by Inventor Mohamed Naquib Attala

Mohamed Naquib Attala has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heterocyclic modulators of cannabinoid receptors
    Patent number: 9339486
    Abstract: Heterocyclic compounds which modulate cannabinoid receptors are presented. Pharmaceutical compositions containing these compounds, methods of using these compounds as modulators of cannabinoid receptors and processes for synthesizing these compounds are also described herein.
    Type: Grant
    Filed: February 2, 2015
    Date of Patent: May 17, 2016
    Assignee: The Cleveland Clinic Foundation
    Inventors: Mohamed Naquib Attala, Philippe Diaz
  • HETEROCYCLIC MODULATORS OF CANNABINOID RECEPTORS
    Publication number: 20150148408
    Abstract: Heterocyclic compounds which modulate cannabinoid receptors are presented. Pharmaceutical compositions containing these compounds, methods of using these compounds as modulators of cannabinoid receptors and processes for synthesizing these compounds are also described herein.
    Type: Application
    Filed: February 2, 2015
    Publication date: May 28, 2015
    Inventors: Mohamed Naquib Attala, Philippe Diaz
  • HETEROCYCLIC MODULATORS OF CANNABINOID RECEPTORS
    Publication number: 20100204220
    Abstract: Heterocyclic compounds which modulate cannabinoid receptors are presented. Pharmaceutical compositions containing these compounds, methods of using these compounds as modulators of cannabinoid receptors and processes for synthesizing these compounds are also described herein.
    Type: Application
    Filed: July 14, 2008
    Publication date: August 12, 2010
    Inventors: Mohamed Naquib Attala, Philippe Diaz